Abstract
Introduction: Fatigue is a common complaint in cancer patients and profoundly affects the quality of life of the patients. Therefore, we designed a clinical trial to evaluate the safety and efficacy of Jollab (containing saffron, honey, and rose water) as a tonic beverage in the management of cancer-related fatigue in breast cancer patients. Methods: Seventy-five patients were randomly assigned into two groups, patients received either 4 weeks Jollab or the placebo (20 mL three times daily). Fatigue was assessed with scores of Visual Analogue Fatigue Scale (VAFS), Fatigue Severity Scale (FSS), and Cancer Fatigue Scale (CFS) at weeks 0 and 4 (before and after the intervention). Results: In the Jollab group, VAFS showed a significant decrease (p = 0.000), but in the placebo group, there was no significant difference (p = 0.258). In the Jollab group, FSS decreased significantly (p = 0.000), while in the placebo group, it slightly decreased (p = 0.096). CFS physical and cognitive subscales also showed improvement of fatigue in the Jollab group compared to the placebo group (p < 0.05), but affective subscale score did not show a significant change after the intervention in both groups (p > 0.05). Conclusions: Jollab beverage has significant positive effects on reducing fatigue in women with breast cancer. However, larger-scale trials with further sample size and longer period of the intervention are needed to confirm and develop our preliminary findings.
References
1.
Haghighat
S
, Akbari
ME
, Holakouei
K
, Rahimi
A
, Montazeri
A
. Factors predicting fatigue in breast cancer patients
. Support Care Cancer
. 2003 Aug
;11
(8
):533
–8
. .2.
Cella
D
, Davis
K
, Breitbart
W
, Curt
G
. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors
. J Clin Oncol
. 2001 Jul 15
;19
(14
):3385
–91
.3.
Teunissen
SC
, Wesker
W
, Kruitwagen
C
, de Haes
HC
, Voest
EE
, de Graeff
A
. Symptom prevalence in patients with incurable cancer: a systematic review
. J Pain Symptom Manage
. 2007
;34
(1
):94
–104
.4.
Jabbari
M
, Daneshfard
B
, Emtiazy
M
, Khiveh
A
, Hashempur
MH
. Biological effects and clinical applications of Dwarf Elder (Sambucus ebulus L): a review
. J Evid Based Complementary Altern Med
. 2017
;22
(4
):996
–1001
.5.
Hashempur
MH
, Khademi
F
, Rahmanifard
M
, Zarshenas
MM
. An evidence-based study on medicinal plants for hemorrhoids in Medieval Persia
. J Evid Based Complementary Altern Med
. 2017
;22
(4
):969
–81
. .6.
Samani
NB
, Jokar
A
, Soveid
M
, Heydari
M
, Mosavat
SH
. Efficacy of the hydroalcoholic extract of Tribulus terrestris on the serum glucose and lipid profile of women with diabetes mellitus: a double-blind randomized placebo-controlled clinical trial
. J Evidence-Based Complement Altern Med
. 2016
;21
(4
):NP91
–7
. .7.
Heydarirad
G
, Rezaeizadeh
H
, Choopani
R
, Mosavat
SH
, Ameri
A
. Efficacy of a traditional Persian medicine preparation for radiation-induced xerostomia: a randomized, open-label, active-controlled trial
. J Integr Med
. 2017
;15
(3
):201
–8
.8.
Keyhanmehr
AS
, Kolouri
S
, Heydarirad
G
, Mofid
B
, Mosavat
SH
. Aromatherapy for the management of cancer complications: a narrative review
. Complement Ther Clin Pract
. 2018
;31
:175
–80
. .9.
Finnegan-John
J
, Molassiotis
A
, Richardson
A
, Ream
E
. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue
. Integr Cancer Ther
. 2013 Jul
;12
(4
):276
–90
. .10.
Su
C
, Wang
L
, Grant
S
, Liu
JP
. Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials
. Complement Ther Med
. 2014
;22
(3
):567
–79
.11.
Norouzian
R
, Ghafari
S
, Heydarirad
G
, Fahimi
S
. Development of a honey based tonic syrup for cancer-related fatigue
. Res J Pharmacogn
. 2017
;4
:60
.12.
Pasalar
M
, Choopani
R
, Mosaddegh
M
, Kamalinejad
M
, Mohagheghzadeh
A
, Fattahi
MR
, Efficacy and safety of Jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial
. Explore
. 2015
;11
(3
):199
–207
.13.
Hashempur
MH
, Hashempour
MM
, Mosavat
SH
, Heydari
M
. Rhazes: his life and contributions to the field of dermatology
. JAMA Dermatol
. 2017
;153
(1
):70
. .14.
Akrami
R
, Hashempur
M
, Tavakoli
A
, Nimrouzi
M
, Sayadi
M
, Roodaki
M
, Effects of Fumaria parviflora L on Uremic Pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial
. Jundishapur J Nat Pharm Prod
. 2017
:e39744
. Inpress
.15.
Mosavat
S
, Marzban
M
, Bahrami
M
, Parvizi
MM
, Hajimonfarednejad
M
. Sexual headache from view point of Avicenna and traditional Persian medicine
. Neurol Sci
. 2017
;38
:193
–6
.16.
Sadeghi
S
, Ghaffari
F
, Heydarirad
G
, Alizadeh
M
. Galen’s place in Avicenna’s The Canon of Medicine: respect, confirmation and criticism
. J Integr Med
. 2020
;18
(1
):21
–5
. .17.
Shakeri
A
, Hashempur
MH
, Mojibian
M
, Aliasl
F
, Bioos
S
, Nejatbakhsh
F
. A comparative study of ranitidine and quince (Cydonia oblonga mill) sauce on gastroesophageal reflux disease (GERD) in pregnancy: a randomised, open-label, active-controlled clinical trial
. J Obstet Gynaecol
. 2018
;38
:899
–905
. .18.
19.
Aghili Shirazi
MH
. Qarabadin-e Kabir (Great Pharmacopoeia)
. Tehran
: Institute of Meical History, Islamic Medicine and Complementary Medicine; Iran Medical University
; 1970
.20.
Avicenna. Al-Qanun fi al-Tibb (The Canon of Medicine)
. Tehran
; 2005
.21.
Zhang
Z
, Wang
C-Z
, Wen
X-D
, Shoyama
Y
, Yuan
C-S
. Role of saffron and its constituents on cancer chemoprevention
. Pharm Biol
. 2013
;51
(7
):920
–4
. .22.
Kamalipour
M
, Akhondzadeh
S
. Cardiovascular effects of saffron: an evidence-based review
. J Tehran Heart Cent
. 2011
;6
(2
):59
–61
.23.
Shah
ZA
, Mir
R
, Matoo
JM
, Dar
MA
, Beigh
M
. Medicinal importance of saffron: a review
. J Pharma Phytochem
. 2017
;6
(5
):2475
–8
.24.
Moazen-Zadeh
E
, Abbasi
SH
, Safi-Aghdam
H
, Shahmansouri
N
, Arjmandi-Beglar
A
, Hajhosseinn Talasaz
A
, Effects of saffron on cognition, anxiety, and depression in patients undergoing coronary artery bypass grafting: a randomized double-blind placebo-controlled trial
. J Altern Complement Med
. 2018
;24
(4
):361
–8
. .25.
Bhandari
PR
. Crocus sativus L.(saffron) for cancer chemoprevention: a mini review
. J Tradit Complement Med
. 2015
;5
(2
):81
–7
. .26.
Moghaddasi
MS
. Saffron chemicals and medicine usage
. J Med plants Res
. 2010
;4
(6
):427
–30
.27.
Boskabady
MH
, Shafei
MN
, Saberi
Z
, Amini
S
. Pharmacological effects of Rosa damascena
. Iran J Basic Med Sci
. 2011
;14
(4
):295
–307
.28.
Mahboubi
M
. Rosa damascena as holy ancient herb with novel applications
. J Tradit Complement Med
. 2016
;6
(1
):10
–6
. .29.
Alvarez-Suarez
JM
, Tulipani
S
, Romandini
S
, Bertoli
E
, Battino
M
. Contribution of honey in nutrition and human health: a review
. Med J Nutrition Metab
. 2010
;3
(1
):15
–23
. .30.
Meda
A
, Lamien
CE
, Millogo
J
, Romito
M
, Nacoulma
OG
. Therapeutic uses of honey and honeybee larvae in central Burkina Faso
. J Ethnopharmacol
. 2004
;95
(1
):103
–7
. .31.
Pasalar
M
, Choopani
R
, Mosaddegh
M
, Kamalinejad
M
, Mohagheghzadeh
A
, Fattahi
MR
, Efficacy of jollab in the treatment of depression in dyspeptic patients: a randomized double-blind controlled trial
. J Evid Based Complementary Altern Med
. 2015
;20
(2
):104
–8
. .32.
Valko
PO
, Bassetti
CL
, Bloch
KE
, Held
U
, Baumann
CR
. Validation of the fatigue severity scale in a Swiss cohort
. Sleep
. 2008
;31
(11
):1601
–7
. .33.
Okuyama
T
, Akechi
T
, Kugaya
A
, Okamura
H
, Shima
Y
, Maruguchi
M
, Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients
. J Pain Symptom Manage
. 2000
;19
(1
):5
–14
. .34.
Baresari
ZB
, Abbaszadeh
A
, Heydarirad
G
, Khabazkhoob
M
. The psychometrics of the Persian version of the “cancer fatigue scale” in Iran
. Eur Asian J Biosci
. 2018
;12
(1
):149
–56
.35.
36.
Askari
SF
, Mohagheghzadeh
A
, Azadi
A
, Jahromi
BN
, Tansaz
M
, Badr
P
. A brief review on vaginal drug delivery in traditional Persian medicine
. Tradit Integr Med
. 2018
;3
(4
):223
–9
.37.
Mofid
B
, Rezaeizadeh
H
, Termos
A
, Rakhsha
A
, Mafi
AR
, Taheripanah
T
, Effect of processed honey and royal jelly on cancer-related fatigue: a double-blind randomized clinical trial
. Electron Physician
. 2016
;8
(6
):2475
–82
. .38.
Biswal
BM
, Sulaiman
SA
, Ismail
HC
, Zakaria
H
, Musa
KI
. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients
. Integr Cancer Ther
. 2013
;12
(4
):312
–22
. .39.
Sadeghian
M
, Rahmani
S
, Zendehdel
M
, Hosseini
SA
, Zare Javid
A
. Ginseng and cancer-related fatigue: a systematic review of clinical trials
. Nutr Cancer
. 2021
;73
(8
):1270
–81
. .40.
Choi
M-K
, Song
I-S
. Interactions of ginseng with therapeutic drugs
. Arch Pharm Res
. 2019
;42
(10
):862
–78
. .41.
Ashtiani
AR
, Seied Amirhossein
L
, Jadidi
A
, Ghasami
K
, Khanmohamadi Hezave
A
, Aghae Pour
S M
, The effect of novel simple saffron syrup on fatigue reduction in patients with multiple sclerosis
. J Basic Clin Physiol Pharmacol
. 2020
;31
(6
). .42.
Khori
V
, Alizadeh
AM
, Yazdi
H
, Rakhshan
E
, Mirabbasi
A
, Changizi
S
, Frequency-dependent electrophysiological remodeling of the AV Node by Hydroalcohol Extract of Crocus sativus L.(Saffron) during experimental atrial fibrillation: the role of endogenous nitric oxide
. Phyther Res
. 2012
;26
(6
):826
–32
. .43.
Abadibavil
D
, Dashti
S
. Investigating the effect of saffron on anxiety, fatigue, labor pain and vaginal childbirth
. Malaysian J Med Heal Sci
. 2021
;17
(2
):270
–5
.44.
Hirsch
GE
, Viecili
PRN
, de Almeida
AS
, Nascimento
S
, Porto
FG
, Otero
J
, Natural products with antiplatelet action
. Curr Pharm Des
. 2017
;23
(8
):1228
–46
. .45.
Arimitsu
J
, Hagihara
K
, Ogawa
K
. Potential effect of saffron as an antiplatelet drug in patients with autoimmune diseases
. J Altern Complement Med
. 2014
;20
(5
):A90
. .46.
Heidari
Z
, Daei
M
, Khalili
H
, Sahebkar
A
. Bleeding complication in a patient with concomitant use of rivaroxaban and saffron supplement: a case report
. Cardiovasc Hematol Disord Drug Targets
. 2022
. Online ahead of print.47.
Kyriakoudi
A
, Ordoudi
SA
, Roldán-Medina
M
, Tsimidou
MZ
. Saffron, a functional spice
. Austin J Nutr Food Sci
. 2015
;3
(1
):1059
.48.
Moshiri
M
, Vahabzadeh
M
, Hosseinzadeh
H
. Clinical applications of saffron (Crocus sativus) and its constituents: a review
. Drug Res
. 2015
;65
(6
):287
–95
. .49.
50.
Heydarirad
G
, Choopani
R
, Pasalar
M
, Parvizi
MM
, Hajian
P
, Mirzaei
HR
. The effect of a chickpea-based persian diet on cancer-related fatigue in breast cancer patients: a semi-experimental study
. Complement Med Res
. 2019
;26
(6
):390
–7
. .51.
Bower
JE
. Cancer-related fatigue: mechanisms, risk factors, and treatments
. Nat Rev Clin Oncol
. 2014
;11
(10
):597
–609
. .52.
Jacobsen
PB
, Donovan
KA
, Weitzner
MA
. Distinguishing fatigue and depression in patients with cancer
. Semin Clin Neuropsychiatry
. 2003
;8
(4
):229
–40
.53.
Bower
JE
. Cancer-related fatigue: links with inflammation in cancer patients and survivors
. Brain Behav Immun
. 2007
;21
(7
):863
–71
. .54.
Liu
L
, Mills
PJ
, Rissling
M
, Fiorentino
L
, Natarajan
L
, Dimsdale
JE
, Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy
. Brain Behav Immun
. 2012
;26
(5
):706
–13
. .55.
Wang
XS
, Williams
LA
, Krishnan
S
, Liao
Z
, Liu
P
, Mao
L
, Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy
. Brain Behav Immun
. 2012
;26
(5
):699
–705
. .56.
Thayer
JF
, Lane
RD
. The role of vagal function in the risk for cardiovascular disease and mortality
. Biol Psychol
. 2007
;74
(2
):224
–42
. .57.
Stein
PK
, Kleiger
RE
. Insights from the study of heart rate variability
. Annu Rev Med
. 1999
;50
(1
):249
–61
. .58.
LaVoy
ECP
, Fagundes
CP
, Dantzer
R
. Exercise, inflammation, and fatigue in cancer survivors
. Exerc Immunol Rev
. 2016
;22
:82
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
